Population specific reference ranges of CD3, CD4 and CD8 lymphocyte subsets among healthy Kenyans

  • Erick M Bosire1Email author,

    Affiliated with

    • Anthony K Nyamache2,

      Affiliated with

      • Michael M Gicheru1,

        Affiliated with

        • Samoel A Khamadi3,

          Affiliated with

          • Raphael W Lihana3 and

            Affiliated with

            • Vincent Okoth3

              Affiliated with

              AIDS Research and Therapy201310:24

              DOI: 10.1186/1742-6405-10-24

              Received: 15 May 2013

              Accepted: 5 November 2013

              Published: 7 November 2013

              Abstract

              Background

              The enumeration of absolute CD4 counts is of primary importance for many medical conditions especially HIV infection where therapeutic initiation depends on the count. These ranges tend to vary across populations. However, these ranges have not been comprehensively established in the Kenyan population. Therefore, this study aimed at establishing the reference ranges for the CD4 and CD8 T-lymphocytes in normal healthy individuals in Kenya.

              Methods

              A total of 315 individuals of the ages between 16 and 60 years old, in 5 different regions of the country, were recruited into the study. They were screened for diseases that potentially cause lymphocyte homeostasis perturbation. CD4/CD8 Counts were performed by use of a FACSCalibur flow cytometer (Becton-Dickinson, NJ) equipped with automated acquisition and analysis software. Results were analysed according to age, sex and region.

              Results

              Results were presented as means and ranges (in parenthesis) generated non parametrically as 2.5 and 97.5 percentiles as follows; In general population; CD3 1655 (614-2685 cells/μL ), CD4 920 (343-1493 cells/μL), and CD8 646 (187-1139 cells/μL), while according to sex, females; CD3 1787 (697-2841 cells/μL), CD4 1010 (422-1572 cells/μL), CD8 659 (187-1180 cells/μL); males; CD3 1610 (581-2641 cells/μL), CD4 889(320-1459 cells/μL) and CD8 644 (185-1140 cells/μL). The general reference ranges for CD4/CD8 ratios were as follows; general population 1.57(0.50-2.74), males 1.51(0.49-2.64) and females 1.69(0.55-2.95).

              Conclusion

              The lymphocyte reference ranges for the Kenyan population are fairly comparable to those established in other African populations. The ranges also differ appreciably from those established in Germany, Italy and Switzerland. Furthermore, the study reported significant differences in the ranges of different population clusters within Kenya, as well us between males and females.

              Keywords

              CD4/CD8 count Lymphocyte subsets HIV-1 Flow cytometry Reference ranges

              Introduction

              Lymphocytes co-ordinate the immune system’s response and play a central role in cell mediated immunity [1]. Lymphocyte subset may include; Helper T cells (CD4 T-cells), Cytotoxic T cells (CTLs or CD8 T-cells), Memory T cells and Regulatory T cells (Treg cells). Upon encounter with antigens, CD4 T cells become activated and proliferate rapidly secreting cytokines that sends signals and maintain active immune response. On the other hand, the CD8 T-cells destroy virally infected cells and tumor cells, and remain inactivated when there is no foreign antigen. In human immunodeficiency virus-1 (HIV-1) infected individuals, lymphocytes (specifically CD4 T-cells) are the viral prime targets. Therefore in these individuals, a CD4 count provides a picture of immune system competence, with higher CD4 counts typically signifying healthier immune systems [1, 2]. In such application, flow cytometry is used to provide absolute counts, percentages and or ratios of these lymphocyte subsets. Besides HIV management, flow cytometric analysis of peripheral blood lymphocyte phenotypes has proven a useful aid in managing a wide range of medical conditions, including autoimmunity, immunodeficiency, infection, malignancy and transplantation [35]. Essential to the effective application of this approach is availability of accurate reference values against which results can be meaningfully compared.

              Reference ranges that are currently used in Kenya are derived from data obtained from Caucasians who are not African Kenyans. In addition, these ranges do not include age and sex which are very important factors that influence lymphocyte counts [6]. Furthermore, several factors have been associated with these differences in lymphocyte counts. These may include; demographic and genetic factors, current exposure to infectious diseases and behavioral factors on CD3, CD4 and CD8 in HIV-negative populations [1, 2, 6]. Averagely, healthy African and Asian populations have been shown to have lower CD4 lymphocyte counts than their western European and Caucasian counterparts [2, 7, 8]. In addition, women tend to have higher CD4 levels than men with comparable demographic and behavioral patterns [8, 9]. However, there is still limited data from specific countries to confirm these differences.

              The pattern of lymphocyte generation has been shown to affect the levels of circulating lymphocytes in males, females and individuals of different ages. The pattern of T lymphocyte generation in aging has been associated with dynamic changes in thymic and extrathymic functions along with sequential developmental steps from cells to mature cells [10]. Increased absolute numbers of peripheral blood CD4 cells in females compared to males have been reported [11]. This is perhaps due to androgens which accelerate thymocytes apoptosis and subsequently influence T cell repertoire with males tending to have less CD4 cells than females [12, 13]. Sex and age related variations in the lymphocyte subsets contribute to age and sex related diseases including autoimmune disorders in females and leukemia or lymphoma in males and elderly patients [14, 15]. Other factors which have received little attention but also affect the normal lymphocyte levels include; dietary patterns, body mass index and smoking habits [1618]. The influence of these many factors point out to the fact that the reference ranges of one population might not be accurately used as a reference range for another. This might give an inaccurate interpretation of the immune status of the individuals.

              Several efforts to establish reference ranges have indicated differences in lymphocyte levels between African and Western populations [2, 3, 9, 19]. In one community in Kenya, general clinical ranges have been shown to significantly differ from the ranges from other parts of the continent [20]. These ranges are also appreciably different from those reported in a neighboring country [21]. The two studies in Kenya had indicated a possibility of having remarkably different ranges of lymphocyte subsets within the Kenyan population [20, 22]. This necessitates the need for a comprehensive reference range establishment using subjects from different regions of the country. In this study we report comprehensive reference ranges for CD3, CD4 and CD8 cutting across representative regions of the country. The study provides ranges specific for males, females and for different ages.

              Materials and methods

              Study subjects and samples

              A total of 315 adults (222 men and 85 female) were recruited into the study after giving consent. This study was ethically approved by Kenya National ethical Review committee before execution. The individuals who were included in the study were healthy adults between 16 and 55 (categorized as 16-19, 21-30 and 31-55) years of age presenting for routine blood donation at the regional centers. These regional blood transfusion centers included; Mombasa, Nakuru, Kisumu, Embu, and Nairobi. A structured questionnaire was used to collect information on the history and general health status of the donors (See Additional file 1). Donors who confirmed to have a history of conditions that cause immune perturbations were excluded from the study. Further, the samples were screened for HIV, Hepatitis B virus (HBV), Hepatitis C virus (HCV), malaria, and syphilis after blood collection, and samples that tested positive were excluded from the study. Blood samples were collected by venipuncture into EDTA vacutainer tubes and analyzed immediately after collection.

              Screening for malaria, syphilis, HIV, HCV and HBV

              Enzyme linked immunoassays were used in screening for these conditions. Commercially available kits containing purified antigens were used. The kits included: ICE* Syphilis, Murex anti-HCV (version 4.0), Hepanostika HBsAg Ultra kit, Murex HIV-1.2.0 (Abbot) and malaria antigen detection kit (Creative diagnostics).

              Sample collection and analysis

              The lymphocyte subsets were analyzed on a FACSCalibur flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, California) with three monoclonal antibodies (BD Tritest CD4-FITC/CD8-PE/CD3-PerCP reagent) according to the manufacturer’s instructions. The FACSCaliber was calibrated and reconfirmed daily using the BD Calibrite beads and BD-FACSComp software, version 2.0 for setting the photomultiplier tube voltages, setting the fluorescence compensation and checking instrument sensitivity before use. A control sample of commercially available whole blood was run daily to optimize the instrument settings. The CD45 versus the side scatter (SSC) dot plot was visually inspected to make sure they appear as a bright compact cluster, with low SSC. Analysis did not proceed if populations were diffuse and if there was little or no separation between clusters [15].

              Data analysis

              Non parametric reference range determination was employed by estimating the 2.5 and 97.5 percentile [23]. The significance of differences between the mean absolute counts and percentages of the Lymphocyte subsets were estimated using the Analysis of Variance (ANOVA) and T-test. Multiple comparisons were done using Tukey’s test. Correlation analysis was applied in determining the relationship between lymphocyte subset levels and age.

              Results

              Among the 315 individuals between the ages 16-60 years, 61.7% (222) were men and 38.4% (85) were female. Their blood samples were analyzed for CD3, CD4 and CD8 lymphocyte subset for establishment of reference ranges. These reference ranges were also compared across the sampled geographical regions, by age as well as sex.

              General distribution of the T-lymphocytes for the study population

              The CD3, CD4 and CD8 counts and ranges for the general study population were determined. The means, median, percentages and ranges of these lymphocytes, as well as the CD4/CD8 ratios were determined (Table 1).
              Table 1

              The means and medians of the lymphocyte subsets in the study population

              T lymphocyte subset

               

              CD3

              CD4

              CD8

              Ratios

              Absolute count*

              %×

              Absolute count*

              %×

              Absolute count*

              %×

              CD4/CD8

              Mean

              1655

              67

              920

              37

              646

              26

              1.57

              Median

              1580

              67

              884

              37

              559

              25

              1.47

              Ranges

              614-2685

              50-78

              343-1493

              24-48

              187-1139

              13-36

              0.50-2.74

              *Expressed as cells/μL of blood.

              × Expressed as a percentage of total lymphocytes.

              Lymphocyte subsets in the different Kenyan regions

              Mean absolute counts of the different regions were compared using ANOVA. Significantly different means were further subjected to Tukey’s test to show differences between each of the regions. The difference in the mean CD3 of Nairobi and Rift valley regions was minimal compared to the difference in the CD3 mean of the Lake Victoria basin region. The Lake Victoria region had the lowest CD3 mean compared to all other regions. These differences in the CD3 absolute count means were significant. General reference ranges were also determined as mentioned earlier (P < 0.05; Table 2).
              Table 2

              Means, medians and ranges of the lymphocyte subsets for the different geographical regions in Kenya

              Region

              Lymphocyte subset

               

              CD3 count

              CD3%

              CD4 count

              CD4%

              CD8 count

              CD8%

              Nairobi

              Mean ± SD

              1841 ± 486c

              69 ± 6a

              1046 ± 283c

              39 ± 6a

              717 ± 260c

              26 ± 5c

              Median

              1824

              69

              1007

              39

              691

              26

              Range

              908-2661

              55-79

              517-1506

              27-48

              266-1165

              16-35

              Eastern

              Mean ± SD

              1728 ± 642b

              64 ± 7a

              949 ± 209b

              37 ± 7b

              650 ± 329ab

              24 ± 6ab

              Median

              1617

              64

              959

              37

              529

              22

              Range

              813-2512

              47-77

              512-1320

              21-50

              213-1083

              11-34

              Rift valley

              Mean ± SD

              1876 ± 883d

              67 ± 8b

              1029 ± 559ab

              37 ± 7c

              752 ± 421d

              27 ± 8b

              Median

              1666

              68

              902

              36

              640

              26

              Range

              660-3074

              50-80

              345-1703

              23-47

              217-1315

              13-39

              Lake Victoria

              Mean ± SD

              1195 ± 449abcd

              66 ± 7c

              690 ± 263abc

              38 ± 6d

              454 ± 231acd

              25 ± 7d

              Median

              1137

              67

              630

              38

              401

              24

              Range

              471-1886

              50-77

              275-1081

              26-47

              135-791

              12-36

              Coast

              Mean ± SD

              1617 ± 574a

              66 ± 7d

              881 ± 333a

              36 ± 7a

              675 ± 289a

              28 ± 6a

              Median

              1502

              67

              854

              36

              602

              28

              Range

              572-2708

              51-77

              281-1540

              22-47

              210-1179

              16-37

              The absolute counts of CD4, CD3 and CD8 are presented as cells/μL of blood.

              Means followed by the same letters within a column are not significantly different from each other according to Tukey’s test.

              T-lymphocyte subset for males and females

              Females had a significantly higher CD3 mean absolute counts (P < 0.05) compared to men. There were significant differences in CD4 counts for males and females. However, there were no significant differences in the mean CD8 absolute counts. T lymphocyte subset reference ranges for males and females separately were also determined at 2.5 and 97.5 percentiles (Table 3).
              Table 3

              Means, medians and ranges of the lymphocyte subsets for males and females

              Lymphocyte subset

              Sex

              p-value

              Female

              Male

              CD3 Absolute count *

              N

              85

              222

               

              Mean

              1787

              1610

              0.039

              Median

              1701

              1529

              0.016

              Ranges

              697-2841

              581-2641

               

              CD3% ˟

              Mean

              68

              66

              0.026

              Median

              69

              66

              0.024

              Ranges

              54-78

              49-78

               

              CD8 Absolute count *

              Mean

              659

              644

              0.743

              Median

              568

              558

              0.696

              Ranges

              187-1180

              185-1140

               

              CD8% ×

              Mean

              25

              26

              0.133

              Median

              25

              25

              0.256

              Ranges

              14-34

              13-37

               

              CD4 Absolute count *

              Mean

              1010

              889

              0.011

              Median

              991

              855

              0.001

              Ranges

              422-1572

              320-1459

               

              CD4% ×

              Mean

              40

              37

              0.001

              Median

              39

              36

              0.001

              Ranges

              23-53

              24-46

               

              CD4/CD8 ratio

              Mean

              1.69

              1.51

              <0.001

              Median

              1.62

              1.44

              0.030

              Ranges

              0.55-2.95

              0.49-2.64

               

              *Expressed as cells/μL of blood.

              × Expressed as a percentage of total lymphocytes.

              T-lymphocyte subset for the different age groups

              The means and medians of the lymphocyte subsets were also determined for the different age groups. There were no significant differences in the mean absolute counts in the age groups that were considered in this study (Table 4).
              Table 4

              The lymphocyte subset levels in the different age groups

              Subset

              Age group

              16-19

              20-30

              31-55

              P value

              CD3 Absolute count*

              N

              55

              196

              62

               

              Mean

              1603

              1641

              1742

              0.745

              Median

              1519

              1611

              1622

              0.595

              CD3% ×

              N

              55

              196

              62

               

              Mean

              65

              67

              67

              0.180

              Median

              65

              67

              67

              0.261

              CD8 Absolute count *

              N

              52

              181

              61

               

              Mean

              611

              641

              693

              0.870

              Median

              526

              564

              636

              0.498

              CD8% ×

              N

              52

              181

              61

               

              Mean

              24

              26

              27

              0.138

              Median

              23

              25

              26.

              0.090

              CD4 Absolute count *

              N

              55

              196

              62

               

              Mean

              912

              898

              997

              0.139

              Median

              915

              882

              988

              0.254

              CD4% ×

              N

              55

              196

              62

               

              Mean

              38

              37

              38

              0.222

              Median

              36

              37

              37

              0.184

              CD4/CD8 ratio

              Mean

              1.70

              1.54

              1.54

              <0.001

              Median

              1.63

              1.45

              1.51

              0.135

              *Expressed as cells/μL of blood.

              × Expressed as a percentage of total lymphocytes.

              ANOVA was used to test the differences in means of the lymphocytes in the age groups.

              Comparison of the ranges of the current study with those established by other studies

              The reference ranges established in this study showed variations with the ones used in MultiSET (BD FACScaliber) as well as other studies in different populations. The studies compared below included normal (HIV negative) populations in their study populations. Most of the studies were regional, that is, having been conducted in specific countries or in some specific regions within the countries (Table 5).
              Table 5

              Comparison of the reference ranges developed in this study with reference ranges of other populations

              Subset

              Kenya

              MultiSET

              Tanzania

              Ghana

              Italy

              Germany

              Switzerland

              CD3*

              613.9048-2685.439

              690-2540

              NA

              NA

              600-2460

              780-2240

              540-1790

              CD3% ×

              50.3433-78.0606

              55-84

              NA

              NA

              NA

              NA

              NA

              CD4*

              343.5796-1493.167

              410-1590

              312.2-1367.6

              265-1932

              490-1670

              490-1640

              310-1140

              CD4% ×

              23.7048-48.2465

              31-60

              NA

              NA

              NA

              NA

              NA

              CD8*

              187.1348-1139.389

              190-1140

              168.2-996.8

              162-1590

              220-1110

              170-880

              140-820

              CD8% ×

              13.3894-36.3925

              13-41

              NA

              NA

              NA

              NA

              NA

              CD4/CD8 ratio

              0.5002-2.7434

              NA

              1.1-2.5

              0.58-4.59

              NA

              0.9-5.0

              1.0-5.0

              NANot available.

              *Expressed as cells/μL of blood.

              × Expressed as a percentage of total lymphocytes.

              Kenya-Current study, MultiSET-BD Biosciences, Tanzania [19], Ghana [2], Italy [24], Germany [25], Switzerland [3].

              Discussion

              The reference values of the main circulating lymphocyte subsets have been established by many studies throughout the world and have shown some variability according to geographical locations and methodology. Results in Table 5 show comparative values of CD3, CD4 and CD8 subsets levels from other countries, showing variations based on geographical region and platform methods used.

              In this study, the mean CD3 count was found to be generally higher compared to those reported in Sweden (1075) but lower in CD3% mean [3]. In comparison with other African countries the lymphocyte counts and percentages were found to be fairly comparable in some cases but in others slightly different. In addition, Kenya like many African countries (Tanzania, Ghana, Senegal and Ethiopia) had lower lymphocyte subset levels compared to those reported in Sweden [3, 25, 26].

              Considering the two important lymphocyte subsets CD4 and CD8, there were striking variations with the other reported ranges within and outside Africa. The mean CD8 value for this study was similar to those obtained in other African countries but slightly higher than those reported in Tanzania and Senegal [8, 25]. The CD4 absolute counts were significantly higher than those reported in Ethiopia and Senegal [17] but lower compared to those reported in Kampala Uganda [21]; Table 5. However, the ranges cannot be conclusively compared since the studies differ in experimental set up. For example the study in Uganda included patients who visited an AIDS information center in Kampala, whereas our study was among blood donors across the country. In comparison to other countries outside Africa, the CD4 absolute counts were higher compared to Asian populations [27]. It can be speculated that, these differences in the lymphocyte counts are due to the many factors already mentioned, including genetic predisposition [13]. Many of these factors including the genetic influence have not been comprehensively confirmed.

              In this study, females had higher absolute counts for CD3 and CD4 lymphocytes compared to males. This was probably due to biological factors (Table 4). It has been speculated that gender and age-related variations within the immune system parameters may contribute to the pathogenesis of several gender and age-related diseases such as autoimmune disorders in female patients [17, 19, 24]. Further, it has been shown that there are gender differences in the generation of CD8 cells during HIV-1 infection, due to increased immune activation compared to men [28]. However, a comparison of mean CD8 absolute counts between males and females, revealed no significant differences. These findings were consistent with previous studies [2, 3, 19, 24].

              The study also compared the differences in absolutes counts across regions. There were significant differences across regions with Lake Victoria region, consistently recording lower lymphocyte counts compared to other regions. The CD8 absolute count of Nairobi were appreciably similar with ones reported by Embree [19] in their controls of a study carried out in Nairobi. These observations show that, there is need to understand the impact of genetic makeup and altitude on the levels of T lymphocytes. The CD4 median absolute counts for the Rift valley (810 cells/μL) were similar to the ones reported in one of the studies in Kericho which is located within the valley ([20] Table 2).

              Analysis of the lymphocyte subsets in the different age groups revealed no significant differences. A more comprehensive study design might be required to give a clear picture of the lymphocyte changes with advancing age. It is however well known that the pattern of T lymphocyte generation with age originates from dynamic changes in thymic as well as extrathymic functions, along with sequential developmental steps from stem cell to ultimately mature cells [29].

              Conclusion

              Our study has established ranges and reveals that lymphocyte subsets among the Kenyan population are different from those of other populations in the other populations such as Germany, Italy and Switzerland. However, the ranges are fairly comparable to those reported in some African countries. The ranges are also slightly different from those that are being used currently. This study has established reference ranges for the lymphocyte subsets among healthy Kenyan individuals of the ages between 16-60 years using FACSCalibur flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, California). The study has further shown the possibility of having varied lymphocyte levels among Kenyan subpopulations, due to many unconfirmed factors. Therefore, the current ranges should be more comprehensively determined and further revised, in order to have accurate comparisons during flow cytometry.

              Abbreviations

              HIV: 

              Human immunodefieciency virus

              CTL: 

              Cytotoxic T lymphocytes

              SSC: 

              Side scatter

              ANOVA: 

              Analysis of variance.

              Declarations

              Acknowledgements

              The authors wish to thank individuals who participated in the study, the staff of all the Regional Blood Transfusion centers for their participation and the Department of Zoological Sciences, Kenyatta University for financial support.

              Authors’ Affiliations

              (1)
              Department of Zoological Science, Kenyatta University
              (2)
              Department of Plant and Microbial Sciences, Kenyatta University
              (3)
              Kenya Medical Research Institute, Centre for Viral Research

              References

              1. Ahmadi K, Hall M, Norman P, Vaughan R, Snieder H, Spector T, Lanchbury J: Genetic determinism in the relationship between human CD4 and CD8 T lymphocyte populations. Genes Immunol. 2001, 2: 38-387.View Article
              2. Ampofo W, Torpey K, Mukadi Y, Koram K, Nolan K, Amenyah R, Kaitoo E, Antwi P, Ofori-adjei D, Lamptey P: Normal CD4T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern Region of Ghana. Viral Immunol. 2006, 19: 260-266. 10.1089/vim.2006.19.260View ArticlePubMed
              3. Bisset L, Lung T, Kaelin M, Ludwig E, Dubs R: Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur J Haematol. 2004, 72: 203-212. 10.1046/j.0902-4441.2003.00199.xView ArticlePubMed
              4. Illoh O: Current applications of flow cytometry in the diagnosis of primary immunodeficiency diseases. Arch Pathol Lab Med. 2004, 128: 23-31.PubMed
              5. Davis W, Hamilton M: Uses of flow cytometry to characterize immunodeficiency syndromes in Camelids. Small Ruminant Res. 2006, 61 (2): 187-193.View Article
              6. Ullrich K, Koenigsmann M, Mohren M, Franke A: Lymphocyte subsets’ reference ranges in an age-and gender-balanced population of 100 healthy adults—a monocentric German study. Clin Immunol. 2005, 116: 192-197. 10.1016/j.clim.2005.03.020View Article
              7. Howard R, Fasano C, Frey L, Miller C: Reference intervals of CD3, CD4, CD8, CD4/CD8, and absolute CD4 values in Asian and non-Asian populations. Cytometry. 1996, 26: 231-232. 10.1002/(SICI)1097-0320(19960915)26:3<231::AID-CYTO9>3.0.CO;2-HView ArticlePubMed
              8. Mandy F, Nicholson J, McDougal J: Revised guidelines for performing single-platform absolute CD4+ T-Cell determinations with CD45 gating for persons infected with human immunodeficiency virus. MMWR. 2003, 52: 1-13.PubMed
              9. Klose N, Coulibaly B, Tebit D, Nauwelaers F, Spengler H, Kynast-Wolf G, Kouyaté B, Kräusslich H, Böhler T: Immunohematological reference values for healthy adults in Burkina Faso. Clin Vaccine Immunol. 2007, 14: 782-784. 10.1128/CVI.00044-07PubMed CentralView ArticlePubMed
              10. Lahita R: Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am. 2000, 26: 951-968. 10.1016/S0889-857X(05)70178-2View ArticlePubMed
              11. Vajpayee M, Kaushik S, Sreenivas V, Wig N, Seth P: CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications. Clin Exp Immunol. 2005, 141: 485-490. 10.1111/j.1365-2249.2005.02857.xPubMed CentralView ArticlePubMed
              12. Kalayjian R, Landay A, Pollard R, Taub D, Gross B, Francis I, Sevin A, Pu M, Spritzler J, Chernoff M, Namkung A, Fox L, Martinez A, Waterman K, Fiscus S, Sha B, Johnson D, Slater S, Rousseau F, Lederman M: Age related immune dysfunction in health and in human immunodefieciency virus (HIV) disease: association of age and HIV infection with naive CD8 cell depletion, reduced expression of CD28 on CD8 cells and reduced thymic volumes. J Infect Dis. 2003, 187: 1924-1933. 10.1086/375372View ArticlePubMed
              13. Olsen N, Kovacs W: Effects of androgens on T and B lymphocyte development. Immunol Res. 2001, 23: 281-288. 10.1385/IR:23:2-3:281View ArticlePubMed
              14. Clerici M, Butto S, Lukwiya M: Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5: Italian–Ugandan AIDS project. AIDS. 2000, 14: 2083-2092. 10.1097/00002030-200009290-00003View ArticlePubMed
              15. Menard D, Joelle M, Bem M, Kassa E, Gresenguet G, Talarmin A: Immunohematological reference ranges for adults from the central African republic. Clin Diagn Lab Immunol. 2003, 10: 443-445.PubMed CentralPubMed
              16. Schaberge T, Theilacker C, Nitschke O, Lode H: Lymphocyte subsets in peripheral blood and smoking habits. Lung. 1997, 175: 387-394. 10.1007/PL00007585View Article
              17. Mair C, Hawes S, Agne H, Sow P, N’dove I, Manhart L, Fu P, Gottlieb G, Kiviat N: Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals. Clin Exp Immunol. 2007, 151: 432-440.View Article
              18. Feldman G, Minkoff H, Schneider F: Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women’s interagency HIV study. Am J Pub Health. 2006, 96: 1060-1065. 10.2105/AJPH.2005.062745.View Article
              19. Ngowi B, Mfinanga S, Bruun J, Morkve O: Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Infect Dis. 2009, 9: 1-7. 10.1186/1471-2334-9-1PubMed CentralView ArticlePubMed
              20. Kibaya R, Bautista C, Sawe F, Schaffer D, Sateren W, Scott P, Michael N, Robb M, Birx D, Souza M: Reference ranges for the clinical laboratory derived from a rural population in Kericho Kenya. PloS ONE. 2008, 3 (10): e3327-Doi:10.1371/journal.pone.0003327PubMed CentralView ArticlePubMed
              21. Tugume S, Piwowar E, Lutalo T, Mugyenyi P, Grant R, Mangeni F, Pattishall K, Katongole-Mbidde E: Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol. 1995, 2: 233-235.PubMed CentralPubMed
              22. Embree J, Bwayo J, Nagelkerke N, Njenga S, Nyange P, Ndinya-Achola J, Pamba H, Plummer F: Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Pediatr Infect Dis J. 2001, 20: 397-403. 10.1097/00006454-200104000-00006View ArticlePubMed
              23. How to define and determine reference intervals in the clinical laboratory; approved guideline. 2000, 20: 13-C28-A2, Wayne, PA: National Committee for Clinical Laboratory Standards, 2
              24. Santagostino A, Garbaccio G, Pistorio A, Bolis V, Camisasca G, Pagliaro P, Girotto M: An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. Haematologica. 1999, 84: 499-504.PubMed
              25. Koetz K, Bryl E, Spickschen K, O’Fallon W, Goronzy J, Weyand C: T-cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 2000, 97: 9203-9208. 10.1073/pnas.97.16.9203PubMed CentralView ArticlePubMed
              26. Nicholson J, Stein D, Mui T, Mack R, Hubbard M, Denny T: Evaluation of a method for counting absolute numbers of cells with a flow cytometer. Clin Diagn Lab Immunol. 1997, 4: 309-313.PubMed CentralPubMed
              27. Chng W, Guat B, Tan S, Kuperan P: Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol. 2004, 11: 168-173.PubMed CentralPubMed
              28. Meier A, Chang J, Chan E, Pollard R, Sidhu H, Kulkarni S, Wen T, Lindsay R, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson J, Carrington M, Bosch R, Robbins G, Altfeld M: Sex differences in the Toll-like receptor-mediated response of plasmocytoid dendritic cells to HIV-1. Nat Med. 2009, 15: 955-959. 10.1038/nm.2004PubMed CentralView ArticlePubMed
              29. Globerson A: Thymocytopoiesis in aging: the bone marrow–thymus axis. Arch Gerontol Geriatr. 1997, 24: 141-155. 10.1016/S0167-4943(96)00747-9View ArticlePubMed

              Copyright

              © Bosire et al.; licensee BioMed Central Ltd. 2013

              This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

              Advertisement